Effect of long-term nicorandil therapy on myocardial perfusion parameters according to triphosadenine stress-volume computed tomography in a patient with non-obstructive coronary artery disease: a care report

IF 0.3 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS

Rational Pharmacotherapy in Cardiology Pub Date : 2023-07-11 DOI:10.20996/1819-6446-2023-2913

O. F. Egorkina, G. N. Soboleva, S. Gaman, Y. A. Karpov, S. Ternovoy

引用次数: 0

Abstract

A case of a patient with myocardial perfusion improvement according to volume computed tomography (VCT) of the heart with triphosadenine infusion against the background of optimal therapy, including nicorandil for 3,5 years, is presented. In a patient with an established diagnosis of non-obstructive coronary artery disease (CAD) in 2019, stress-induced myocardial ischemia of left ventricular (LV) septal and lateral area was detected. Repeated investigation 3,5 years later against the background of optimal therapy showed an ischemia decrease in the form of the disappearance of previously detected defects in the basal segments of the anteriorlateral and inferior-lateral walls and the middle segments of the anterior-septal and inferior-lateral walls of the LV.

查看原文本刊更多论文

非阻塞性冠状动脉疾病患者长期服用尼可地尔对三磷腺嘌呤应激容积计算机断层扫描心肌灌注参数的影响：护理报告

本文介绍了一例患者在接受了包括尼可地尔在内的3.5年最佳治疗的背景下，通过输注三磷腺嘌呤进行心脏容积计算机断层扫描（VCT）发现心肌灌注改善的病例。在一名于 2019 年确诊为非阻塞性冠状动脉疾病（CAD）的患者身上，发现了应激诱发的左心室（LV）室间隔和外侧心肌缺血。3.5 年后，在最佳治疗背景下进行的重复检查显示，缺血程度有所减轻，之前在左心室前外侧壁和下外侧壁基底段以及前隔壁和下外侧壁中间段发现的缺损消失了。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Rational Pharmacotherapy in Cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

1.00

自引率

50.00%

发文量

审稿时长

6 weeks

期刊介绍： The primary goals of the Journal are consolidation of information on scientific and practical achievements in pharmacotherapy and prevention of cardiovascular diseases and continuing education of cardiologists and internists. The scientific concept of the edition suggests the publication of information on current achievements in cardiology, the results of national and international clinical trials. The Journal publishes original articles on the results of clinical trials designed to study the effectiveness and safety of drugs, analysis of clinical practice and its compliance with national and international recommendations, expert s’ opinions on a wide range of cardiology issues, associated conditions and clinical pharmacology. There is a heading “Preventive cardiology and public health” in the Journal to stimulate research interest in this highly demanded area. Memories of the outstanding people in medicine including cardiology, which are of great interest to historians of medicine, are published in "Our Mentors” heading.